Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction

被引:260
作者
Roger, Veronique L. [1 ,2 ]
Weston, Susan A. [1 ]
Gerber, Yariv [1 ,6 ]
Killian, Jill M. [1 ]
Dunlay, Shannon M. [2 ]
Jaffe, Allan S. [2 ]
Bell, Malcolm R. [2 ]
Kors, Jan [3 ]
Yawn, Barbara P. [4 ]
Jacobsen, Steven J. [5 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA
[3] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[4] Olmsted Med Ctr, Rochester, MN USA
[5] So Calif Permanente Med Grp, Pasadena, CA USA
[6] Tel Aviv Univ, Sackler Sch Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel
基金
美国国家卫生研究院;
关键词
biomarkers; incidence; mortality; myocardial infarction; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; TEMPORAL TRENDS; OLMSTED COUNTY; CASE-FATALITY; REDEFINITION; MINNESOTA; COMMUNITY; MORTALITY; ASSOCIATION;
D O I
10.1161/CIRCULATIONAHA.109.897249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In 2000, the definition of myocardial infarction (MI) changed to rely on troponin rather than creatine kinase (CK) and its MB fraction (CK-MB). The implications of this change on trends in MI incidence and outcome are not defined. Methods and Results-This was a community study of 2816 patients hospitalized with incident MI from 1987 to 2006 in Olmsted County, Minnesota, with prospective measurements of troponin and CK-MB from August 2000 forward. Outcomes were MI incidence, severity, and survival. After troponin was introduced, 278 (25%) of 1127 incident MIs met only troponin-based criteria. When cases meeting only troponin criteria were included, incidence did not change between 1987 and 2006. When restricted to cases defined by CK/CK-MB, the incidence of MI declined by 20%. The incidence of non-ST-segment elevation MI increased markedly by relying on troponin, whereas that of ST-segment elevation MI declined regardless of troponin. The age-and sex-adjusted hazard ratio of death within 30 days for an infarction occurring in 2006 (compared with 1987) was 0.44 (95% confidence interval, 0.30 to 0.64). Among 30-day survivors, survival did not improve, but causes of death shifted from cardiovascular to noncardiovascular (P=0.001). Trends in long-term survival among 30-day survivors were similar regardless of troponin. Conclusions-Over the last 2 decades, a substantial change in the epidemiology of MI occurred that was only partially mediated by the introduction of troponin. Non-ST-segment elevation MIs now constitute the majority of MIs. Although the 30-day case fatality improved markedly, long-term survival did not change, and the cause of death shifted from cardiovascular to noncardiovascular. (Circulation. 2010; 121:863-869.)
引用
收藏
页码:863 / 869
页数:7
相关论文
共 33 条
  • [1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [2] [Anonymous], 1997, INT CLASSIFICATION D
  • [3] Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
    Antman, EM
    Tanasijevic, MJ
    Thompson, B
    Schactman, M
    McCabe, CH
    Cannon, CP
    Fischer, GA
    Fung, AY
    Thompson, C
    Wybenga, D
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) : 1342 - 1349
  • [4] Temporal trends in the incidence of coronary disease
    Arciero, TJ
    Jacobsen, SJ
    Reeder, GS
    Frye, RL
    Weston, SA
    Killian, JM
    Roger, VL
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (04) : 228 - 233
  • [5] DOES ASPIRIN CONSUMPTION AFFECT THE PRESENTATION OR SEVERITY OF ACUTE MYOCARDIAL-INFARCTION
    COL, NF
    YARZEBSKI, J
    GORE, JM
    ALPERT, JS
    GOLDBERG, RJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (13) : 1386 - 1389
  • [6] Coronary revascularization in the community - A population-based study, 1990 to 2004
    Gerber, Yariv
    Rihal, Charanjit S.
    Sundt, Thoralf M., III
    Killian, Jill A.
    Weston, Susan A.
    Therneau, Terry M.
    Roger, Veronique L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (13) : 1223 - 1229
  • [7] Secular trends in deaths from cardiovascular diseases - A 25-year community study
    Gerber, Yariv
    Jacobsen, Steven J.
    Frye, Robert L.
    Weston, Susan A.
    Killian, Jill M.
    Roger, Veronique L.
    [J]. CIRCULATION, 2006, 113 (19) : 2285 - 2292
  • [8] Trends in severity of hospitalized myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1994
    Goff, DC
    Howard, G
    Wang, CH
    Folsom, AR
    Rosamond, WD
    Cooper, LS
    Chambless, LE
    [J]. AMERICAN HEART JOURNAL, 2000, 139 (05) : 874 - 880
  • [9] Temporal trends in cardiogenic shock complicating acute myocardial infarction
    Goldberg, RJ
    Samad, NA
    Yarzebski, J
    Gurwitz, J
    Bigelow, C
    Gore, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1162 - 1168
  • [10] Coronary heart disease death and sudden cardiac death: A 20-year population-based study
    Goraya, TY
    Jacobsen, SJ
    Kottke, TE
    Frye, RL
    Weston, SA
    Roger, VL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (09) : 763 - 770